Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01356602 · BASELINE

Baseline characteristics

Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients · Source last updated 2014-01-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      133
    2. group Id
      BG001
      value
      133
    3. group Id
      BG002
      value
      133
    4. group Id
      BG003
      value
      399
    units
    Participants
groups
  1. description
    Patients on this arm received 150 mg subcutaneously (s.c.) at randomization and upon new flare. The doses were provided as pre-filled syringes. The patients were given 3 injections: two placebo and one active drug.
    id
    BG000
    title
    Canakinumab, Pre-filled Syringes (PFS)
  2. description
    The patients on this arm received 150 mg s.c. at randomization and upon new flare. The doses were provided as lyophilized power and had to be reconstituted with water for injection before application. The patients were given 3 injections: two placebo and one active drug.
    id
    BG001
    title
    Canakinumab, Lyophilizate (LYO)
  3. description
    The patients on this arm received 40 mg intramuscular (i.m.) at randomization and upon new flare. The patients were given 3 injections: two placebo and one active drug.
    id
    BG002
    title
    Triamcinolone Acetonide
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          11.21
          value
          53.4
        2. group Id
          BG001
          spread
          11.84
          value
          53
        3. group Id
          BG002
          spread
          11.33
          value
          53.7
        4. group Id
          BG003
          spread
          11.44
          value
          53.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        2. group Id
          BG001
          value
          9
        3. group Id
          BG002
          value
          11
        4. group Id
          BG003
          value
          35
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          118
        2. group Id
          BG001
          value
          124
        3. group Id
          BG002
          value
          122
        4. group Id
          BG003
          value
          364
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      133
    2. group Id
      BG001
      value
      133
    3. group Id
      BG002
      value
      133
    4. group Id
      BG003
      value
      399
    units
    Participants
groups
  1. description
    Patients on this arm received 150 mg subcutaneously (s.c.) at randomization and upon new flare. The doses were provided as pre-filled syringes. The patients were given 3 injections: two placebo and one active drug.
    id
    BG000
    title
    Canakinumab, Pre-filled Syringes (PFS)
  2. description
    The patients on this arm received 150 mg s.c. at randomization and upon new flare. The doses were provided as lyophilized power and had to be reconstituted with water for injection before application. The patients were given 3 injections: two placebo and one active drug.
    id
    BG001
    title
    Canakinumab, Lyophilizate (LYO)
  3. description
    The patients on this arm received 40 mg intramuscular (i.m.) at randomization and upon new flare. The patients were given 3 injections: two placebo and one active drug.
    id
    BG002
    title
    Triamcinolone Acetonide
  4. description
    Total of all reporting groups
    id
    BG003
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          spread
          11.21
          value
          53.4
        2. group Id
          BG001
          spread
          11.84
          value
          53
        3. group Id
          BG002
          spread
          11.33
          value
          53.7
        4. group Id
          BG003
          spread
          11.44
          value
          53.5
    dispersion Type
    STANDARD_DEVIATION
    param Type
    MEAN
    title
    Age, Continuous
    unit Of Measure
    Years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          15
        2. group Id
          BG001
          value
          9
        3. group Id
          BG002
          value
          11
        4. group Id
          BG003
          value
          35
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          118
        2. group Id
          BG001
          value
          124
        3. group Id
          BG002
          value
          122
        4. group Id
          BG003
          value
          364
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice